Clinical Trials
4 trialsNCT06101134 2026-04-09
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
Bristol-Myers Squibb
Phase 2 Active not recruiting
NCT05415215 2026-02-10
ProHer
Hoffmann-La Roche
Phase 3 Completed
NCT05573022 2025-11-17
IMPACTT
Vejle Hospital
Phase NA Completed
NCT07158892 2025-09-08
Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
University of Texas at Austin
Phase NA Not yet recruiting